TCL Archive Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer November 20, 1992
TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive In Brief: Construction Grant Application Deadline for 75-25% Funding Oct. 1; Fordham Quits April 29, 1977
